video still
Monoclonal antibody
Georges Köhler and César Milstein
The 1975 hybridoma technique solved one problem: how to make unlimited quantities of identical antibodies targeting a known antigen. It did not solve delivery, safety, scalability, or therapeutic function. Its value lies in reproducibility — not potency, not novelty of target, not clinical impact.
